Sernova Biotherapeutics SEOVF Stock
Sernova Biotherapeutics Price Chart
Sernova Biotherapeutics SEOVF Financial and Trading Overview
| Sernova Biotherapeutics stock price | 0.14 USD |
| Previous Close | 0.68 USD |
| Open | 0.67 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.65 - 0.67 USD |
| 52 Week Range | 0.5 - 1.08 USD |
| Volume | 15.63K USD |
| Avg. Volume | 17.88K USD |
| Market Cap | 197.17M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SEOVF Valuation Measures
| Enterprise Value | 170.87M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.1320753 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.269 |
Trading Information
Sernova Biotherapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -38.095% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.08 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 0.65 USD |
| 200-Day Moving Average | 0.68 USD |
SEOVF Share Statistics
| Avg. Volume (3 month) | 17.88K USD |
| Avg. Daily Volume (10-Days) | 3.56K USD |
| Shares Outstanding | 303.33M |
| Float | 260.63M |
| Short Ratio | N/A |
| % Held by Insiders | 14.46% |
| % Held by Institutions | 0.049% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -63.27% |
| Return on Equity (ttm) | -112.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -32432032 USD |
| Net Income Avi to Common (ttm) | -31404072 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.6M USD |
| Total Cash Per Share (mrq) | 0.12 USD |
| Total Debt (mrq) | 208.93K USD |
| Total Debt/Equity (mrq) | 0.65 USD |
| Current Ratio (mrq) | 6.282 |
| Book Value Per Share (mrq) | 0.106 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24050764 USD |
| Levered Free Cash Flow (ttm) | -14584641 USD |
Profile of Sernova Biotherapeutics
| Country | United States |
| State | ON |
| City | London |
| Address | The Stiller Centre |
| ZIP | N6G 4X8 |
| Phone | N/A |
| Website | https://www.sernova.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells;a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform; and research collaboration with AstraZeneca PLC to evaluate novel potential therapeutic cell applications. The company was incorporated in 1998 and is headquartered in London, Canada.
Q&A For Sernova Biotherapeutics Stock
What is a current SEOVF stock price?
Sernova Biotherapeutics SEOVF stock price today per share is 0.14 USD.
How to purchase Sernova Biotherapeutics stock?
You can buy SEOVF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sernova Biotherapeutics?
The stock symbol or ticker of Sernova Biotherapeutics is SEOVF.
Which industry does the Sernova Biotherapeutics company belong to?
The Sernova Biotherapeutics industry is Biotechnology.
How many shares does Sernova Biotherapeutics have in circulation?
The max supply of Sernova Biotherapeutics shares is 328.49M.
What is Sernova Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Sernova Biotherapeutics PE Ratio is now.
What was Sernova Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Sernova Biotherapeutics EPS is -0.06 USD over the trailing 12 months.
Which sector does the Sernova Biotherapeutics company belong to?
The Sernova Biotherapeutics sector is Healthcare.